Le Lézard
Classified in: Health, Business
Subject: BUSINESS CONTRACTS

Emblem Selects No Fixed Address as its Agency of Record



TORONTO, March 19, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (TSXV:EMC.WT) ("Emblem" or the "Corporation") is pleased to announce that it has selected No Fixed Address ("NFA") as its agency of record, following a Request for Proposal process that included five agencies. Through the partnership, NFA and Emblem will work together on marketing communication needs and brand initiatives ahead of legalization, with in-market activities set to begin in early Q2.

Further details on the selection were published in Strategy Online:

http://strategyonline.ca/2018/03/19/emblem-picks-no-fixed-address-as-aor/

About Emblem

Emblem Corp. is a fully integrated licensed producer and distributor of medical cannabis and cannabis derivatives in Canada under the ACMPR (Access to Cannabis for Medical Purposes Regulations). Led by a team of cannabis experts and former health care and pharma executives, it has three distinct verticals ? cannabis production, patient education centers, and pharmaceutical dosage form development. Emblem trades under the ticker symbol "EMC" on the TSX Venture Exchange.

About No Fixed Address

NFA is a full-service creative and digital agency designed to provide clients with the experience of a roster of proven talent and an entrepreneurial underpinning to it all. We approach every client challenge with an open mind allowing us to provide a tailored solution that puts your business first. We have no fixed agenda other than to share our true passion for the business that we're in and to make our clients successful.

We are fortunate to work with a range of clients including Questrade, MLSE, J.P. Wiser's, Disney, Canadian Centre for Child Protection, Sunnybrook Health Sciences Centre, RioCan, and Mattamy Homes.

NFA is proud to be ranked as the #3 Digital Agency in Canada in 2017 by Strategy Magazine.

Forward-looking statements

This news release may contain "forward-looking information" and "forward-looking statements" within the meaning of applicable Canadian securities legislation, including, without limitation, statements regarding the use of proceeds from the Offering and the future results of operations, performance and achievements of the Corporation. All information contained herein that is not clearly historical in nature may constitute forward-looking information. Except as required by law, the Corporation disclaims any obligation to update or revise any forward-looking statements. Readers are cautioned not to put undue reliance on these forward-looking statements. This news release contains information obtained by the Corporation from third parties and believes such information to be accurate but has not independently verified such information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information contact:

Ali Mahdavi
Emblem Corp.
(416) 962-3300
alimahdavi@emblemcorp.com


These press releases may also interest you

at 16:30
In conjunction with DURECT Corporation's first quarter 2018 financial results press release, you are invited to listen to a conference call that will be broadcast live over the internet on Wednesday, May 2, 2018 at 4:30 pm Eastern Time (1:30 pm...

at 16:29
Northwell Health's Feinstein Institute for Medical Research Professor John, M Kane, MD, has been inducted into the prestigious Association of American Physicians (AAP). AAP's members are competitively selected and are among the leading senior...

at 16:20
Today, NewYork-Presbyterian celebrated the opening of the NewYork-Presbyterian David H. Koch Center, a world-class ambulatory care center that combines innovative clinical approaches and cutting-edge technology to provide exceptional care and a...

at 16:15
Bio-Techne Corporation announced today that it has hired Kim Kelderman as President, Diagnostics and Genomics, effective April 30, 2018.  Mr. Kelderman will be based in California and will lead Bio-Techne's diagnostics business; he will also drive...

at 16:15
Mirati Therapeutics, Inc. (the Company or Mirati), a clinical-stage targeted oncology company, today provided a progress update on its lead development programs and announced updated, positive clinical trial data for sitravatinib, a spectrum...

at 16:15
Edwards Lifesciences Corporation , the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended March 31, 2018. ...




News published on 19 march 2018 at 16:03 and distributed by: